Global
CN
EN
HOME
ABOUT US
About Laekna
Core Management Team
Board of Directors
Milestones
Scientific Advisory Board
Core Investors
Honors & Awards
R&D
R&D
Therapeutic Areas
Candidates
Pipeline
Clinical Trials
PARTNERSHIPS
Strategic Partners
Business Development
Holistic Approach
BD Contact
INVESTORS
Corporate Governance
Financial Results
Announcements and Circulars
IR Calendar
Listing Documents
NEWS
Press Releases
Media Coverage
CAREERS
Global Team
Career Development
Jobs
My Laekna
CONTACT US
Contact Us
Leave Message
RSS Feeds
INVESTOR RELATIONS
CURE FOR A BETTER FUTURE
Scroll down to see more
Announcements and Circulars
2024
2023
March 11, 2024
[VOLUNTARY ANNOUNCEMENT] -
SUBMISSION OF INVESTIGATIONAL NEW DRUG APPLICATION FOR LAE102 FOR THE TREATMENT OF OBESITY TO THE U.S. FOOD AND DRUG ADMINISTRATION
More
March 07, 2024
Announcements and Notices -
[Date of Board Meeting]
More
March 05, 2024
[Monthly Returns] -
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
More
March 01, 2024
Circulars -
[Other] Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
More
March 01, 2024
Circulars -
[Other] Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
More
February 29, 2024
[VOLUNTARY ANNOUNCEMENT] -
THE CENTRE FOR DRUG EVALUATION OF THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ACCEPTED THE INVESTIGATIONAL NEW DRUG APPLICATION FOR LAE102
More
<
1
3
4
5
6
7
>
RSS Feeds
If you want to know more about Laekna, please fill in the form below and sign up for emails:
Name
*
Email
*
Company
Occupation
News
Positions
Follow us on Linkedin
HOME
ABOUT US
R&D
PARTNERSHIPS
INVESTORS
NEWS
CAREERS
CONTACT US
PRIVACY POLICY
占位
Global
—English
|
中国
—简体中文
